Monheit Law Blog Home By Month Articles
Celebrex Lawsuits Vioxx Lawsuits Truck Accident Lawsuits Serzone Lawsuits Prempro Lawsuits Welder's Disease Lawsuits Ewing's Sarcoma Lawsuits Risperdal Lawsuits Crestor Lawsuits Mesothelioma Lawsuits Zprexa Lawsuits Bextra Lawsuits
|
: : : 2005-01-10
SUPREME COURT SET TO ENTER TORT BATTLEGROUND
January 10, 2005 08:56
As the White House and Congress gear up for yet
another run at tort "reform," two cases set for
argument at the Supreme Court underline the crucial
role the justices also play in the policy debate
over how much litigation is too much. While
legislative efforts to limit lawsuits have mostly
fizzled in recent years, the Supreme Court has
arguably done more in the field than either of the
elected branches by cutting back on punitive damages
and restricting, at least modestly, class actions.
The justices will have the final word on whatever
measures, if any, Congress does pass, in their classic
role of statutory interpretation. The two cases, one
a closely watched securities fraud class action and
the other involving liability for pesticide makers,
both involve laws that were aimed, at least in part,
at protecting key industries from excessive
litigation. The Court is being called on to
interpret ambiguous wording in the statutes that
could lead, ironically, to significantly more tort
lawsuits, not fewer. Parties in both cases have
enlisted top-tier lawyers to do battle. In the
pesticide case Bates v. Dow Agrosciences, heavy
hitters David Frederick of Washington, D.C.'s
Kellogg, Huber, Hansen, Todd, Evans & Figel, will
square off against former Solicitor General Seth
Waxman of Wilmer Cutler Pickering Hale and Dorr.
Frederick represents Texas peanut farmers harmed by
a pesticide made by Waxman's client, Dow. Waxman
will argue that a federal law that regulates
pesticides pre-empts state tort actions, but
Frederick calls that argument "the latest effort by
manufacturers to evade liability for their defective
products through a sweeping pre-emption argument."
Dura Pharmaceuticals Inc. v. Broudo could determine
the future course of shareholder fraud-on-the-market
actions against corporations. "The biggest
securities litigation case in a decade" is how
William Sullivan of Paul, Hastings, Janofsky &
Walker in San Diego describes the case.
*****
Tony Mauro, Legal Times, Law.com, 01/10/2005
For complete story, search
http://www.law.com
$ - Only subscribers can access this article
*****
«
»
|